HB 2236 establishes Missouri's "Infertility Access Program" through the Department of Health and Senior Services to improve fertility treatment access. The program provides travel assistance, lodging stipends, or telehealth subsidies for individuals in rural or medically underserved areas seeking care at certified fertility clinics. It also creates an "Infertility Access Fund" for program administration, requires health carriers to publish clear fertility coverage summaries, and mandates annual reports on treatment utilization, geographic barriers, and demographic data. The bill directly affects patients in underserved regions, certified fertility clinics, and health insurance providers offering fertility coverage.
HB 1774 creates a Missouri state income tax credit for individuals who donate to qualifying local hospital foundations. It allows taxpayers to claim a credit equal to 50% of their donation amount (capped at $2,500 annually per taxpayer), provided the foundation is a 501(c)(3) organization that provides financial relief for unpaid hospital bills in the donor’s area. The credit is non-refundable, cannot exceed total state income tax liability, and has a $2 million annual cap across all taxpayers. This policy directly affects Missouri residents who pay state income tax and make qualifying donations to hospital foundations, aiming to incentivize charitable support for community healthcare access.
HB 2489 requires state-funded organizations providing pregnancy-related services (like family planning, abortion care, prenatal care, or adoption counseling) to share medically accurate and unbiased information about all reproductive health options - including birth control, pregnancy, adoption, and postpartum care. To qualify for state funding, these organizations must provide information verified by medical research, recognized by major health bodies (such as the American College of Obstetricians and Gynecologists or CDC), or aligned with national medical guidelines. The bill defines "medically accurate" through three specific criteria to ensure information is evidence-based and objective. This applies directly to clinics and providers seeking state financial support for pregnancy-related services. The bill is currently pending in committee (prefiled December 2025, read twice January 2026).
SB 1479 allows state health agencies to adopt existing Medicaid regulations by simply referencing them in new rules, rather than rewriting the full text. This directly affects agencies that create Medicaid-related rules, such as the Department of Health, by streamlining their rulemaking process. The key mechanism is "incorporating by reference," meaning agencies can cite approved Medicaid rules from other sources instead of duplicating them. This reduces administrative burden and ensures consistency with established Medicaid standards. The bill does not change Medicaid benefits or eligibility, only the process for agencies to update their rules.
SB 929 requires health insurance plans to cover self-administered hormonal contraceptives (such as pills, patches, or rings) without cost-sharing, meaning no copays or deductibles. This directly affects individuals who use these contraceptives and their insurance providers. The key provision mandates that insurers include these specific methods in their coverage, aligning with broader contraceptive access standards. The bill focuses on eliminating financial barriers to commonly used, non-prescription-dependent birth control options.
HB 1875 requires health care providers in Missouri to notify patients before providing nonemergency care if they are out-of-network for the patient's health insurance plan. Before such care, providers must check the patient's insurance coverage and their own network status, and if out-of-network, they must inform the patient or the person consenting for the patient. This notification must occur prior to treatment and complements existing federal protections like the No Surprises Act. The bill directly affects health care providers and patients receiving nonemergency care in Missouri.
SB 1350 requires health insurance plans in Missouri to cover non-opioid medications for acute pain without restrictions, effective January 1, 2027. It directly affects enrollees (insurance policyholders) prescribed non-opioid drugs for pain expected to last 30 days or less. The bill prohibits insurers from denying coverage for these medications, forcing patients to try opioids first, or charging higher out-of-pocket costs for non-opioid drugs compared to opioids. This applies to all health benefit plans issued or renewed after the effective date, aiming to expand access to non-opioid pain treatment options.
SB 897 limits when health insurance companies can require prior authorization for medical services. It mandates that insurers must approve at least 90% of prior authorization requests from a provider for a specific service in the previous six-month period before requiring authorization. The bill also requires insurers to notify providers within 25 days of such determinations, establish appeal processes, and maintain an online portal for tracking authorization decisions. This primarily affects health insurance companies and healthcare providers in Missouri who participate in commercial health plans (excluding Medicaid managed care).
SB 1433 would create a sales tax exemption for qualifying diabetic supplies, such as insulin and testing strips, directly affecting people with diabetes who purchase these essential medical products. The bill would remove state sales tax from these supplies, lowering out-of-pocket costs for patients. This policy change applies specifically to medical items used in managing diabetes, as defined by the bill's provisions. The measure is currently in early stages, having been prefilled and receiving its first reading.
HB 2194 allows students with asthma or anaphylaxis to self-administer prescribed epinephrine devices in school after meeting specific requirements. Schools must authorize this only if a physician approves a treatment plan, the student demonstrates proper skill, and parents sign a liability waiver acknowledging no school liability for non-negligent self-administration. The bill also permits trained school staff to use epinephrine devices during emergencies without civil liability, following established protocols. It requires schools to maintain emergency medication access and report all epinephrine use to emergency health providers. The law directly affects students with chronic conditions, schools, and school staff managing health emergencies.
